Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach

Table 3 Cumulative cost effectiveness/savings after 5, 10, 25, and 50 years of vaccination program. Cost savings is achieved within 6 years considering indirect costs and within 8 years if indirect costs are excluded. Values are for the entire population

Cumulative outcomes	Universal Vaccination
Cumulative outcomes	5 y	10 y	25 y	50 y
QALY’s Gained^a	4800	10,521	24,144	37,502
Vaccination Cost (millions)	$9.40	$17.52	$35.76	$52.83
Disease Cost Avoided (millions)	$8.06	$18.60	$47.78	$81.41
Indirect cost avoided (millions)	$0.99	$2.61	$8.00	$14.03
Total Cost Savings(millions, including indirect costs)	–	$3.69	$20.03	$42.60
Total Cost Savings(millions, excluding indirect cost)	–	$1.09	$12.02	$28.57
ICER^b ($/QALY, including indirect costs)	75	Cost saving	Cost saving	Cost saving
ICER ($/QALY, excluding indirect cost)	281	Cost saving	Cost saving	Cost saving

ISSN: 1471-2334